CWC
VCYT icon

Carolinas Wealth Consulting’s Veracyte VCYT Stock Holding History

Carolinas Wealth Consulting’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47
Closed -$1.4K – 905
2025
Q1 		$1.4K Buy
47
+3
+7% +$114 ﹤0.01% 865
2024
Q4 		$1.71K Buy
44
+19
+76% +$719 ﹤0.01% 860
2024
Q3 		$846 Hold
25
– – ﹤0.01% 946
2024
Q2 		$539 Sell
25
-4
-14% -$84 ﹤0.01% 983
2024
Q1 		$649 Buy
+29
New +$707 ﹤0.01% 959

Other funds holding VCYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Carolinas Wealth Consulting's VCYT Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 47 shares — an estimated $1.4K sold.

Carolinas Wealth Consulting first reported a position in VCYT in Q1 2024 and held it in 5 quarters. The position peaked at $1.71K in Q4 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 47 Veracyte shares in Q2 2025, an estimated $1.4K.
  • Carolinas Wealth Consulting first reported a position in Veracyte in Q1 2024 and held it in 5 quarters.
  • Carolinas Wealth Consulting's Veracyte position peaked at $1.71K in Q4 2024.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.